XML 20 R11.htm IDEA: XBRL DOCUMENT
v3.22.2

Other current and non-current assets | 6 Months Ended
--- | ---
Jun. 30, 2022
Text Block [Abstract] |
Other current and non-current assets | 5. Other current and non-current assets
|  | As of |
|  | June 30, 2022 |  |  | December 31, 2021 |
|  | (Euros in thousands) |
Prepaid expenses |  |  | 6,573 |  |  |  | 3,781 |
Value added tax receivable |  |  | 947 |  |  |  | 915 |
Grant receivable |  |  | 830 |  |  |  | 762 |
Other assets |  |  | 2,336 |  |  |  | 950 |
Other current assets |  |  | 10,686 |  |  |  | 6,408 |
The Group recognizes receivables for government grants, when it is reasonably assured that the grant will be received, and all contractual conditions have been complied with. As of June 30, 2022, and December 31, 2021, no receivables were considered impaired. Prepaid expenses include expenses for licenses and software of €4.5 million as of June 30, 2022 and €0.5 million as of December 31, 2021 and prepaid insurance expenses of €0.2 million as of June 30, 2022 and €1.3 million as of December 31, 2021. The Group accrued €0.5 million as of June 30, 2022 and €0.7 million as of December 31, 2021 of incremental cost for the successful arrangement of the BMS collaboration signed in 2019 and the Genmab collaboration agreement. Additionally, prepaid expenses include expenses for maintenance of €0.5 million as of June 30, 2022 and €0.8 million as of December 31, 2021. The remaining amount is mainly related to CRO expenses and prepaid rent. Other assets include receivables from capital gains tax of €0.3 million as of June 30, 2022 and €0.3 million as of December 31, 2021. Furthermore, other assets include receivables from lease incentive of €1.1 million as of June 30, 2022. The remaining amount is mainly related to prepaid deposit expenses.
|  | As of |
|  | June 30, 2022 |  |  | December 31, 2021 |
|  | (Euros in thousands) |
Prepaid expenses |  |  | 4,678 |  |  |  | 636 |
Other non-current assets |  |  | 4,678 |  |  |  | 636 |
Other non-current assets include the non-current portion of prepayments for licensing agreements of €4.2 million, prepaid maintenance expenses of €0.3 million and accrued incremental cost of the BMS and Genmab collaboration agreement of €0.2 million as of June 30, 2022.

X
- Definition The disclosure of other assets. [Refer: Other assets] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 10 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfOtherAssetsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Text block. + References No definition available. + Details
Name: | imtx_TextBlockAbstract
Namespace Prefix: | imtx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration